Streamlining Ophthalmology SMART on FHIR Prior Auth Workflows

Klivira transforms ophthalmology SMART on FHIR prior auth by embedding automation directly into your EMR, eliminating manual steps and accelerating critical eye care.

Revenue cycle directors and prior authorization coordinators in ophthalmology face unique challenges, from managing chronic anti-VEGF injection cycles to navigating complex premium IOL and glaucoma surgery requirements. Traditional PA processes, often requiring context-switching and manual data entry, hinder efficiency and delay patient access to care. Klivira addresses these bottlenecks by integrating directly into your clinical workflow.

The Demands of Ophthalmology Prior Authorization

Ophthalmology practices manage a high volume of prior authorizations, particularly for chronic conditions requiring ongoing anti-VEGF injections and specialized surgical procedures like premium IOL cataract surgery or glaucoma interventions. These workflows are often characterized by repetitive re-authorizations and a critical need for precise clinical documentation, making them ripe for automation to reduce administrative burden and ensure timely patient treatment.

Key Prior Authorization Triggers in Ophthalmology

  • Anti-VEGF intravitreal injections (e.g., Aflibercept, Ranibizumab, Faricimab) for conditions like wet AMD and DME.
  • Cataract surgery with premium intraocular lenses (IOLs) or specific specialty lens technology.
  • Glaucoma surgical procedures, including micro-invasive glaucoma surgery (MIGS) and traditional interventions.
  • Corneal procedures such as DSAEK, DMEK, and corneal cross-linking for keratoconus.
  • Oculoplastic procedures like functional blepharoplasty for visual-field-affecting ptosis.

Transforming Workflows with SMART on FHIR

Traditional prior authorization workflows often force clinicians and staff to exit the EMR, manually transfer patient context, and manage PA processes in disparate systems. Klivira's SMART on FHIR integration eliminates this context-switching by launching the PA workflow directly from within the EMR. This approach leverages SMART App Launch to automatically pull patient and encounter data, streamlining the process and reducing the risk of manual transcription errors.

Operational Benefits of SMART on FHIR for Ophthalmology

  • Eliminate Context-Switching: Launch PA workflows directly from Epic, Cerner, athenahealth, or MEDITECH without leaving the patient chart.
  • Automated Data Pull: Leverage FHIR R4 to automatically extract US Core resources, including patient demographics and clinical context, for accurate submissions.
  • Structured Write-Back: Record PA decisions and status updates directly into the EMR as structured DocumentReference, Communication, or Task resources.
  • Reduced Manual Errors: Minimize transcription errors by automating the transfer of patient and encounter-specific information.
  • Accelerated Approvals: Expedite approval times by ensuring complete, accurate, and timely submission of prior authorization requests.

Klivira's Tailored Approach for Ophthalmology

Klivira specifically addresses the nuances of ophthalmology prior authorization by incorporating AAO Preferred Practice Patterns into its automation logic. Our platform supports high-volume anti-VEGF re-authorization cycles, manages biosimilar substitution routing based on payer policies, and aids in the complex cosmetic-vs-medical determination for oculoplastic procedures. By integrating with leading EMRs via SMART on FHIR, Klivira ensures that critical OCT findings and visual acuity documentation are seamlessly included in PA submissions.

Foundational Standards for Integrated Prior Authorization

  • SMART App Launch: The secure framework for launching applications directly from the EMR, providing patient and encounter context.
  • US Core IG: The baseline FHIR R4 resource profiles used for exchanging clinical data, ensuring interoperability.
  • Da Vinci CRD (Coverage Requirements Discovery): Enables real-time identification of PA requirements at the point of care.
  • Da Vinci DTR (Documentation Templates and Rules): Facilitates automated assembly of required clinical documentation.
  • Da Vinci PAS (Prior Authorization Support): Standardizes the electronic submission of prior authorization requests.

Frequently asked questions

How does Klivira handle the recurring nature of anti-VEGF injection prior authorizations?

Klivira's platform is designed to manage chronic treatment cycles common in retina practices. It automates the re-authorization workflow for anti-VEGF injections, incorporating AAO-guideline-aware logic to ensure that necessary documentation, such as current visual acuity and OCT findings, is included for ongoing treatment cycles, reducing manual effort and potential delays.

Which EMR systems are compatible with Klivira's SMART on FHIR ophthalmology prior auth solution?

Klivira integrates with major EMR platforms that support SMART on FHIR, including Epic, Cerner, athenahealth, and MEDITECH. Our solution leverages the SMART App Launch standard to embed prior authorization workflows directly into these systems, ensuring a consistent user experience regardless of the underlying EMR.

What specific clinical documentation is critical for ophthalmology PAs, and how does Klivira help?

For ophthalmology, critical documentation includes diagnosis confirmation (e.g., OCT showing fluid for anti-VEGF), visual acuity, prior treatment response, and visual field tests for glaucoma or functional blepharoplasty. Klivira automates the extraction of these US Core FHIR resources from the EMR, ensuring comprehensive and accurate submissions aligned with payer policies and AAO Preferred Practice Patterns.

How does SMART on FHIR integration prevent manual data entry errors in prior authorization?

SMART on FHIR eliminates manual data entry by automatically launching Klivira from the EMR with patient and encounter context. This means patient demographics, member IDs, and relevant clinical data are pulled directly via FHIR R4, removing the need for staff to retype information and significantly reducing transcription errors that can lead to denials.

Does Klivira address biosimilar substitution requirements for anti-VEGF medications?

Yes, Klivira's platform incorporates logic for biosimilar substitution. It routes prior authorization requests according to specific payer policies regarding brand-name anti-VEGF medications versus their biosimilar alternatives, helping practices comply with formulary requirements and avoid denials related to incorrect drug selection.

What is the relationship between Da Vinci PAS and SMART on FHIR in ophthalmology prior authorization?

SMART on FHIR provides the secure, EMR-integrated launch mechanism for prior authorization applications. Da Vinci PAS (Prior Authorization Support) is a FHIR-based implementation guide that standardizes the electronic exchange of prior authorization requests and responses. Together, they enable a seamless, automated workflow where Klivira launches via SMART on FHIR and then executes Da Vinci PAS for efficient submission and communication of PA decisions.

Related coverage

Other ophthalmology prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo